Sign up to Seedtable
Get unlimited access to our database of 17,248 companies. Cancel anytime.
Full database access with no contact information. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Full database access with verified contact info. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
All of Pro, plus we'll exclude your top three competitors as new Intel customers.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Free plan includes the ability to browse the database and a list of the top 10 companies of the week, every Tuesday in your email. You need to upgrade if you want to see more than 10 companies, sort, filter or export data.
world-class organizations
69 Best Health Tech Startups to Watch in 2024
How do we build this list? TLDR: Using math and experts.
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
Sign up to Seedtable Intel to access the entire database
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Gene-editing platform. |
$30M · Series B | Sanofi Ventures, Khosla Ventures, Bpifrance | 11 to 50 | Health Tech, Biotech | Paris, France | •••••••••••@eligo.bio | ||
Workflow automation platform for the life sciences industry. |
$40M · Series B | Dimension, Local Globe, Hummingbird Ventures | 51 to 100 | Health Tech, Machine Learning | B2B | London, UK | •••••••••••@automata.tech | |
Biomedical research discovery tool. |
$60M · Series B | Index Ventures, ICONIQ Growth, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Robots for surgery. |
$55M · Series B | Sofinnova Partners, Cathay Innovation | 11 to 50 | Health Tech, Hardware, Deep Tech, Robotics, Manufacturing | B2B | Paris, France | •••••••••••@moonsurgical.com | |
Oral macrocycle drug discovery platform. |
$28M · Seed | Novo A/S, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@orbismedicines.com | |
Skin care telehealth platform. |
$52M · Series B | Village Global, Index Ventures, Headline | 101 to 250 | Health Tech | B2C | London, UK | •••••••••••@getharley.com | |
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Ulltrasound-based medical devices manufacturer to treat various brain disorders. |
$4M · Series B | Unorthodox Ventures, EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Hardware | B2C | Paris, France | •••••••••••@carthera.eu | |
Cera Care is a London-based technology-enabled home care company. |
$64M | Oltre Venture | 5001 to 10000 | Health Tech, Mobile, Service Industry, ElderTech | B2B, B2C | London, UK | •••••••••••@ceracare.co.uk | |
AI-driven services that aid healthcare providers in delivering timely, accurate care. |
$60M · Series B | Atomico, Eurazeo, Prosus & Naspers | 51 to 100 | Health Tech, Machine Learning | B2B, SaaS | Copenhagen, Denmark | •••••••••••@corti.ai | |
Innovative heart pumps manufacturer. |
$28M · Series C | Bpifrance, Sofinnova Partners, Ysios Capital | 51 to 100 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@corwave.com | |
AI software for radiologists. |
$29M · Series B | Bpifrance, Heal Capital, Elaia | 1 to 10 | Health Tech, AI | B2B | Paris, France | •••••••••••@gleamer.ai | |
Developer of prophylactic vaccine against Group B Streptococcus. |
$57M · Series C | EQT Partners, OrbiMed, Novo A/S | 1 to 10 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@minervax.com | |
Mnemo Therapeutics specializes in biotechnology and life science. |
$89M · Series A | Sofinnova Partners | 101 to 250 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@mnemo-tx.com | |
Payfit allows small and medium enterprises to easily and quickly pay their employees. |
$79M · Series C | Accel, Eurazeo | 251 to 500 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@payfit.com | |
SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases. |
$52M · Series A | Ysios Capital | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Paris, France | •••••••••••@sparingvision.com | |
Withings is a developer of digital health and wellness smart devices such as fitness trackers and watches. |
$60M · Series B | 2050 | 101 to 250 | Health Tech, Hardware, Sportstech, Mobile, Manufacturing, Wearables | B2B | Paris, France | •••••••••••@withings.com | |
Preventative health care platform. |
$65M · Series A | General Catalyst, Atomico, Lakestar | 11 to 50 | Health Tech | B2C | Stockholm, Sweden | •••••••••••@nekohealth.com | |
4D cardiac imaging and navigation platform. |
$21M · Series A | EQT Life Sciences, EIC Accelerator, imec.xpand | 11 to 50 | Health Tech | B2B, SaaS | Dublin, Ireland | •••••••••••@lumavision.com | |
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
Digital health platform for women. |
$5M · Seed | Blisce, Vorwerk Ventures | 1 to 10 | Health Tech | B2C, SaaS | Paris, France | •••••••••••@sorella-care.com | |
Intracellular screening platform. |
$51M · Series A | Columbus Venture Partners, British Patient Capital, Pfizer Venture Investments | 11 to 50 | Health Tech | Southampton, UK | •••••••••••@curvetx.com | ||
Cardiac ablation system developer for treating cardiac arrhythmias. |
$58M · Series B | Advent Life Sciences, Gilde Healthcare, Earlybird Venture Capital | 1 to 10 | Health Tech | Lausanne, Switzerland | •••••••••••@argamedtech.com | ||
Developer of bio-fabricated silk protein materials. |
$27M · Series C | Novo A/S | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Munich, Germany | •••••••••••@amsilk.com | |
Clinical-stage biopharmaceutical company. |
$95M · Series A | Lightstone, GV, ARCH Venture Partners | 51 to 100 | Health Tech, Deep Tech | B2C | Dublin, Ireland | •••••••••••@carricktherapeutics.com | |
Innovative immunotherapies developer for cancer patients. |
$51M | Forbion Capital Partners, Vesalius Biocapital Partners, Novartis Venture Fund | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Munich, Germany | •••••••••••@catalym.com | |
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases. |
$3M · Series F | The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Paris, France | •••••••••••@enterome.com | |
Huma provides a digital health platform used for predictive care and research. |
$25M · Series B | Unilever Ventures, Samsung NEXT | 101 to 250 | Health Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@huma.com | |
Digital pet insurance platform. |
$25M · Series B | Balderton Capital, Felix Capital, Inventure | 1 to 10 | Health Tech, Pet Tech | B2C, Marketplace | Stockholm, Sweden | •••••••••••@lassie.co | |
Lifen is your simple and secure exchange of medical letters assistant. |
$22M · Series B | Daphni, Partech Ventures, Serena | 11 to 50 | Health Tech, Hardware | B2B, SaaS | Paris, France | •••••••••••@lifen.fr | |
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform. |
$21M · Series B | AlbionVC, Earlybird Venture Capital, Partech Ventures | 251 to 500 | Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce | B2B | London, UK | •••••••••••@oviva.com | |
Virtual reality healthcare training platform. |
$12M · Series A | Frog Capital, ACF Investors, QVentures | 1 to 10 | Health Tech, Edtech | B2B, SaaS | London, UK | •••••••••••@oxfordmedicalsimulation.com | |
Quell Therapeutics is a cell therapy company |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
Cybersecurity platform. |
$37M · Series A | Northcap | 101 to 250 | Health Tech, Hardware, Cybersecurity, Manufacturing | B2B, SaaS | Paris, France | •••••••••••@sekoia.io | |
Remote monitoring system for ophthalmic conditions. |
$10M · Series A | Elaia, iBionext, Cap Horn | 11 to 50 | Health Tech | B2C | Paris, France | •••••••••••@tilakhealthcare.com | |
Therapy to treat atrial fibrillation (AF). |
$47M · Series B | Canaan Partners, Novo A/S, Broadview Ventures | 1 to 10 | Health Tech | Copenhagen, Denmark | •••••••••••@acesionpharma.com | ||
AI-powered MRI platform for scanning biological samples. |
$31M · Series A | 83North, TVC, Possible Ventures | 51 to 100 | Health Tech, AI | B2B, SaaS | Munich, Germany | •••••••••••@orbem.ai | |
Mechatronic guidewires manufacturer. |
$6M · Series A | Forepont Capital Partners, NTI Corporation | 11 to 50 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@basecampvascular.com | |
Therapeutic protein developer for chronic neuropathic pain. |
$24M · Series A | Medical Incubator Japan, Borean Innovation, Novo A/S | 1 to 10 | Health Tech, Biotech | Copenhagen, Denmark | •••••••••••@hobatherapeutics.com | ||
AI platform to map the human immune system. |
$14M · Series A | Molten Ventures, Life Extension Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Developer of imaging catheters based on optical coherence tomography (OCT) for cancer treatment. |
$5M · Series A | Santec Corporation, NLC | 1 to 10 | Health Tech, Deep Tech | B2B | Amsterdam, Netherlands | •••••••••••@scinvivo.com | |
AI-powered hypertension management platform. |
$30M · Series A | Khosla Ventures, Molten Ventures, Translink Capital | 51 to 100 | Health Tech, AI | B2C, SaaS | Bern, Switzerland | •••••••••••@aktiia.com | |
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. |
$17M · Seed | AlbionVC, Boxer Capital, Syncona Partners LLP | 101 to 250 | Health Tech, Biotech | B2B | London, UK | •••••••••••@achillestx.com | |
AI-Powered healthcare platform. |
$5M · Seed | Hoxton Ventures, eHealth Ventures, AlbaCore Capital | 1001 to 5000 | Health Tech, AI | B2B, B2C | London, UK | •••••••••••@babylonhealth.com | |
Self-sampling technology. |
$2M · Series A | Sciety, We Venture Capital | 1 to 10 | Health Tech | B2C | Stockholm, Sweden | •••••••••••@capitainer.se | |
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins. |
$50M · Series A | Khosla Ventures, General Catalyst | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
Employee benefits management platform. |
$40M | Balderton Capital, Notion Capital, Speedinvest | 51 to 100 | Health Tech, Fintech | B2B, SaaS | Madrid, Spain | •••••••••••@cobee.io | |
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases. |
$46M | Bioqube Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@egle-tx.com | |
At-home blood testing platform for cancer patients. |
$17M · Series A | Business Growth Fund, Parkwalk Advisors | 11 to 50 | Health Tech | B2B | London, UK | •••••••••••@entia.co | |
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases. |
$30M · Series B | Pureos Bioventures, Karista | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@eyevensys.com | |
Heart failure management app and devices. |
$44M · Series C | Lightstone, Gilde Healthcare, New Enterprise Associates | 1 to 10 | Health Tech, Deep Tech | B2C | Dublin, Ireland | •••••••••••@fire1foundry.com | |
Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle. |
$7M · Series A | Target Global, VNV Global | 251 to 500 | Health Tech, Mobile, Business Intelligence | B2C, Freemium | London, UK | •••••••••••@flo.health | |
Fresha provides an online platform for booking beauty and wellness appointments with local businesses. |
$20M · Series B | Partech Ventures, Target Global, FJ Labs | 251 to 500 | Health Tech, Fashion, Ecommerce | B2B, B2C, SaaS | London, UK | •••••••••••@fresha.com | |
Therapy and coaching platform. |
$20M · Series B | Omers Ventures, Octopus Ventures | 51 to 100 | Health Tech, Fitness | B2B, B2C, Marketplace | London, UK | •••••••••••@helloself.com | |
Treatments for genetic bleeding disorders. |
$135M · Series B | Novo A/S, HealthCap | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Copenhagen, Denmark | •••••••••••@hemab.com | |
Hublo provides software that ease healthcare professionals daily life so that they can focus on taking care of patients. |
$25M · Series A | Revaia, Acton Capital | 51 to 100 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@hublo.com | |
We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake. |
$22M · Series A | Hoxton Ventures, Atomico, Connect Ventures | 11 to 50 | Health Tech, AI | B2B | London, UK | •••••••••••@kheironmed.com | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
Manufacturer of medicines to protect from the threat of respiratory viruses |
$47M | SoftBank Group, GV | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Amsterdam, Netherlands | •••••••••••@leydenlabs.com | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Creandum, Seedcamp | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform. |
$20M | Firstminute Capital | 11 to 50 | Health Tech, AI, Mobile | B2C | Paris, France | •••••••••••@nabla.com | |
Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases. |
$27M · Series A | Sofinnova Partners, Novo A/S, Forbion Capital Partners | 11 to 50 | Health Tech, Biotech | B2B | Amsterdam, Netherlands | •••••••••••@northseatherapeutics.com | |
Numan is a startup which aims to tackle your tackle problem erectile dysfunction. |
$12M · Series A | Anthemis, VNV Global | 11 to 50 | Health Tech, Edtech | B2C | London, UK | •••••••••••@numan.com | |
Ouihelp is a developer of an online residential assistance platform designed to help seniors in their regular activities at home. |
$31M · Series B | Future Positive Capital, XAnge | 51 to 100 | Health Tech | B2B, B2C, Marketplace | Paris, France | •••••••••••@ouihelp.fr | |
Palta is a health and wellbeing technology company |
$14M · Series A | Target Global, VNV Global | 501 to 1000 | Health Tech, Mobile | B2B, B2C | London, UK | •••••••••••@palta.com | |
ReViral is a biotechnology company that develops and offers antiviral therapies for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications. |
$47M | Sofinnova Partners | 1 to 10 | Health Tech, Hardware, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@safeheal.com | |
AI-powered prenatal screening solution. |
$14M · Series A | Bpifrance, Elaia, EIC Accelerator | 11 to 50 | Health Tech, Deep Tech | SaaS | Paris, France | •••••••••••@sonio.ai |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.
Seedtable’s take on Health Tech
By Gonz Sánchez Sarmiento
CEO at Seedtable
Health Tech in Europe is a rapidly growing industry that is transforming medicine. Some of the trends powering this transformation include AI in healthcare, an increased focus on patient data, staff wellness, remote healthcare, and wearables. However, Europe is facing substantial challenges in continuing to deliver high-quality healthcare services to its citizens, including ageing populations, cultural shifts, rigid and complex financing models, increasing costs of innovation, a scarcity of skilled personnel, rising health inequalities, and health complexities stemming from climate change. The European Union has implemented the Regulation on Health Technology Assessment (HTA) to improve the quality of HTA across the Union and ensure an efficient use of resources. The European digital health market is predicted to grow at a CAGR of 27.1% from 2020 to 2025, with the UK, Germany, and France being the largest markets. The use of data and technology in the healthcare and life sciences sectors is expected to continue to enhance the industry, with artificial intelligence and machine learning playing a central role. However, the industry is fragmented, especially when it comes to rules and operational standards across the continent, making it challenging to establish a legal basis to allow the exchange of health data.
- Manufacturing... (2483)
- Fintech... (2385)
- Health Tech... (2376)
- Ecommerce... (1774)
- Mobile... (1594)
- Data and Analytics... (1484)
- Business Intell...... (1462)
- AI... (1454)
- Hardware... (1237)
- Climate Tech & ...... (1020)
- Energy & Nuclear... (949)
- Sales and Marke...... (926)
- Biotech... (916)
- Mobility & Tran...... (913)
- Foodtech... (897)
- Proptech & Real...... (891)
- Deep Tech... (807)
- Media and Enter...... (788)
- Crypto & web3... (673)
- Edtech... (649)
- CPG & Consumer ...... (625)
- Privacy and Sec...... (515)
- Developer Tools... (483)
- Gaming... (479)
- Machine Learning... (471)
- Payments... (465)
- Communications... (459)
- Hiring and Recr...... (448)
- Fashion... (424)
- Community & Lif...... (410)
- Agritech... (386)
- Travel Tech... (378)
- Adtech... (368)
- Sportstech... (348)
- Legal Tech... (346)
- Consumer Social... (294)
- Cybersecurity... (282)
- Video... (280)
- Pharma... (273)
- Robotics... (268)
- Supply Chain & ...... (266)
- Creative Tools... (258)
- Enterprise Soft...... (247)
- Productivity Tools... (245)
- Insuretech... (220)
- Future of Work... (211)
- CRM... (210)
- AR / VR... (206)
- Internet of Things... (202)
- Music and Audio... (198)
- Fitness... (190)
- Cloud... (169)
- Service Industry... (159)
- Food Delivery... (132)
- Investing... (124)
- Space Tech... (119)
- Wearables... (112)
- Identity Manage...... (87)
- Navigation and ...... (83)
- Electric Vehicles... (82)
- Publishing... (77)
- ElderTech... (75)
- Personal Finance... (67)
- Messaging... (63)
- Art... (62)
- Govtech... (60)
- Drones... (58)
- Semiconductor... (58)
- Open Source... (54)
- IT Management... (50)
- Pet Tech... (48)
- Quantum Computing... (43)
- FamilyTech & Pa...... (43)
- Esports... (34)
- Genetics... (29)
- UK (435)
- Germany (247)
- France (263)
- Spain (153)
- Sweden (163)
- Switzerland (147)
- Netherlands (67)
- Italy (50)
- Denmark (92)
- Finland (69)
- Norway (37)
- Ireland (51)
- Belgium (43)
- Poland (44)
- Scotland (45)
- Austria (32)
- London (238)
- Paris (127)
- Berlin (98)
- Stockholm (98)
- Copenhagen (77)
- Barcelona (70)
- Amsterdam (38)
- Munich (53)
- Madrid (40)
- Oslo (22)
- Helsinki (33)
- Zürich (46)
- Dublin (39)
- Milan (21)
- Cambridge (76)
- Vienna (29)
- Brussels (25)
- Lyon (28)
- Manchester (24)
- Glasgow (29)
- Geneva (21)
- Lausanne (38)
- Oxford (21)
- Basel (23)